⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15648448 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL17074955 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL17074956 | 0.98 | — | — | |
| SCHEMBL15968901 | 0.80 | CRBN (0.32) | — | |
| SCHEMBL15968903 | 0.80 | CRBN (0.32) | — | |
| SCHEMBL617664 | 0.79 | — | — | |
| SCHEMBL617665 | 0.79 | — | — | |
| SCHEMBL617929 | 0.79 | — | — | |
| SCHEMBL7404816 | 0.79 | — | — | |
| SCHEMBL24615863 | 0.79 | MAOA (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2909196-B1 | BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY | ASTEX THERAPEUTICS LTD (GB) | 2020-12-02 | — | — | EP | claimed |
| US-8202879-B2 | Quinazoline derivatives having tyrosine kinase inhibitory activity | SHIONOGI & CO., LTD. (JP) | 2012-06-19 | — | — | US | disclosed |
| US-20090143414-A1 | Quinazoline Derivatives Having Tyrosine Kinase Inhibitory Activity | SHIONOGI & CO., LTD. (JP) | 2009-06-04 | — | — | US | disclosed |